ALPHA CF (Schwabe North America, Inc.)
Welcome to the PulseAid listing for the ALPHA CF drug offered from Schwabe North America, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Schwabe North America, Inc. |
| NON-PROPRIETARY NAME: | ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT,IPECAC , PHOSPHORUS |
| SUBSTANCE NAME: | ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2011-08-18 |
| END MARKETING DATE: | 2021-03-31 |
ALPHA CF HUMAN OTC DRUG Details:
| Item Description | ALPHA CF from Schwabe North America, Inc. |
| LABELER NAME: | Schwabe North America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4; 4; 2; 2; 4; 3; 6([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1) |
| START MARKETING DATE: | 2011-08-18 |
| END MARKETING DATE: | 2021-03-31 |
| PRODUCT ID: | 53499-0339_210cc887-bf3a-4deb-9b03-825225f23da1 |
| PRODUCT NDC: | 53499-0339 |
| APPLICATION NUMBER: | |
Other ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS Pharmaceutical Manufacturers / Labelers:
